Non-cystic Fibrosis Bronchiectasis: Clinical Trials

2 trials for Non-cystic Fibrosis Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Non-cystic Fibrosis Bronchiectasis: new trials by email Literature Review of Non-cystic Fibrosis Bronchiectasis trials Research Report on Non-cystic Fibrosis Bronchiectasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
Trikafta - Non-cystic Fibrosis Bronchiectasis
Phase 4CompletedEmory University322023-04-182026-02-09
Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis
Amikacin, Normal saline - Non-Cystic Fibrosis Bronchiectasis
Phase 4CompletedQilu Hospital of Shandong University1782014-03-012019-04-24

Interventions

Amikacin (1)  ·  Saline Solution (1)  ·  elexacaftor (1)  ·  elexacaftor, ivacaftor, tezacaftor drug combination (1)  ·  ivacaftor (1)  ·  tezacaftor (1)

Sponsors

Emory University (1)  ·  Qilu Hospital of Shandong University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Eric Sorscher, MD (1)  ·  Yu Li, Professor (1)

Results publications

PMID 39951444